ASX Watchlist September 2026: What Could Put ALS (ASX:ALQ) on Investors’ Radar?

Sonal Goyal

11 September 2026 05:41 PM AEST

ASX Watchlist September 2026: What Could Put ALS (ASX:ALQ) on Investors’ Radar?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

ALS Limited (ASX:ALQ) provides testing, inspection and certification services across industries including mining, environmental, food and pharmaceuticals.

The company benefits from exposure to both resources activity and regulated testing markets, with growth supported by laboratory demand, minerals exploration and long-term outsourcing trends.

Company Overview

ALS Limited is a global testing and laboratory services provider operating across multiple industries.

The company operates through two main divisions: Life Sciences, which provides environmental, food, pharmaceutical and consumer product testing, and Commodities, which supports mineral exploration, Mining and industrial materials testing.

Its laboratory network spans multiple regions, providing exposure to global resource activity and regulated testing demand.

FY26 Performance

ALS reported its FY26 results for the year ended 31 March 2026, highlighting improved financial performance.

Revenue increased to A$3.32 billion, while underlying net profit after tax rose to A$381.2 million.

The company reported higher underlying EBIT and improved margins, supported by growth across key Business areas.

Business Performance

The Commodities division remained an important contributor, benefiting from improved minerals exploration activity and Demand for testing services.

The Life Sciences division continued supporting the company through environmental, food and pharmaceutical testing markets, where regulatory requirements create ongoing demand.

ALS continues focusing on expanding laboratory capacity and improving service efficiency.

Factors to Watch

Investors are expected to monitor minerals exploration activity, laboratory utilisation rates and progress across expansion projects.

Key areas include demand trends in mining-related testing, recovery in selected life sciences markets and the impact of new laboratory capacity.

The company’s ability to maintain margins while expanding operations will remain important.

Risks

ALS is exposed to cyclical changes in mining exploration activity, which can influence demand for commodities testing.

The company also faces risks related to laboratory expansion, currency movements, operational costs and changes in regulatory requirements.

A slowdown in resource Investment or weaker demand in specific testing markets could affect performance.

Conclusion

ALS enters the second half of 2026 with improved earnings, a diversified testing portfolio and continued investment in laboratory capacity.

The company’s future performance will depend on minerals market conditions, execution of expansion projects and growth across life sciences businesses. For investors following ASX industrial stocks, ALS remains a company to monitor due to its exposure to long-term testing and inspection trends.

FAQs

Q: What does ALS Limited do?

A:ALS Limited provides testing, inspection and certification services across commodities, environmental, food and pharmaceutical industries.

Q: Which industries does ALS serve?

A:ALS serves industries including mining, environmental services, food, pharmaceuticals and industrial materials.

Q: What were ALS Limited’s key FY26 financial results?

A:ALS reported FY26 revenue of A$3.32 billion and underlying net profit after tax of A$381.2 million.

Q: What are the main risks for ALS Limited?

A:Key risks include mining cycle volatility, laboratory expansion challenges, currency movements and changes in testing demand.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.